Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

GXO Reports Preliminary Q1 2024 Results, Revenue Of $2.5B, Est $2.375B; Updates Its 2027 Financial Targets

Author: Benzinga Newsdesk | April 24, 2024 07:16am

Net loss of approximately $36 million, primarily driven by a $63 million expense associated with legacy litigation. Cash and cash equivalents of approximately $423 million.

Organic revenue CAGR (2024-2027) of approximately 10%, to approximately $15.5 billion to $16.0 billion of revenue. Adjusted diluted EPS CAGR (2024-2027) of more than 15%.

Posted In: GXO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist